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Aim of the study
The purpose of this study was to determine whether the
duration of antiarrhythmic therapy after discharge from
the hospital following abdominal surgery is related to the
incidence of atrial fibrillation (AF) recurrence in elderly
patients with the occurrence of peri-operative AF.
Background
The occurrence of peri-operative AF after abdominal sur-
gery is a clinical condition burdened by several complica-
tions, especially in the elderly [1-3]. When AF is
successfully converted to sinus rhythm, it is unlikely to
recur, and nearly all of these patients are discharged from
the hospital in sinus rhythm. It is not clear how soon
these patients may discontinue antiarrhythmic therapy to
avoid drugs side effects without risking recurrence of AF.
The recurrence of AF needs different kind of treat-
ment. Medical therapy includes various antiarrhythmic
drugs to control heart rate and restore sinus rhythm and
anticoagulation to reduce the tromboembolic risk [4].
Overactivation of sympathetic nervous system, related to
surgery stress [5], could be reduced by the treatment
with antiarrhythmic drugs, such as Beta Blockers, and
may reduce the incidence of AF recurrence [6-10].
Methods
A pilot study was conducted in 19 elderly patients (age
> 65 years) who underwent abdominal surgery (right
emicolectomy, sigmoidectomy and anterior rectal resec-
tion) and with occurrence of peri-operative AF that
successfully reverted to sinus rhythm. They were pro-
spectively randomized at dismissal to receive antiar-
rhythmic therapy for 1 week (six patients in group A), 3
weeks (seven patients in group B), or 6 weeks (six
patients in group C). Patients were followed up for an
additional 4 weeks after discontinuation of antiarrhyth-
mic therapy for detection of recurrence of AF.
Results
There was no significant difference in the recurrence
of AF among groups (0%, 2%, and 0% for groups A, B,
and C, respectively).
Conclusions
In elderly patients with peri-operative AF after abdominal
surgery, converted to normal sinus rhythm before hospital
discharge, have a benign course and the duration of antiar-
rhythmic therapy shorter than one week is appropriate.
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